Purepac Approvals Re-Start With Glucophage XR Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA clearance of the company’s ANDA for metformin extended-release could bode well for Purepac’s chances that its generic version of Neurontin tablets will soon be approved. Approval of Purepac’s solid oral dose forms have been on hold due to manufacturing compliance issues.